INDEGENE LIMITED Share Price
INDEGENE LIMITED Share Price Today
As of 5 Jul 2026, INDEGENE LIMITED share price is ₹508.30. The stock opened at ₹522.65, compared to its previous close of ₹514.45. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹505.00 to ₹523.80, with an average price of ₹514.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹414.00 and a high of ₹596.80. On the performance front, INDEGENE LIMITED share price has declined by 2.73% over the last six months and is down 10.23% on a year-on-year basis.
INDEGENE LIMITED Returns Calculator
INDEGENE LIMITED Shareholder Returns
INDEGENE LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
INDEGENE LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,839.30 | ₹2,589.60 | ₹2,306.10 | ₹1,664.61 |
| Other Income | ₹107.20 | ₹76.30 | ₹58.00 | ₹25.89 |
| Total Revenue | ₹2,946.50 | ₹2,665.90 | ₹2,364.10 | ₹1,690.50 |
| Total Expenses | ₹2,407.20 | ₹2,209.70 | ₹2,001.10 | ₹1,417.10 |
| Profit Before Tax | ₹539.30 | ₹458.60 | ₹363.00 | ₹226.50 |
| Tax | ₹132.60 | ₹121.90 | ₹96.90 | ₹63.68 |
| Profit After Tax | ₹406.70 | ₹336.70 | ₹266.10 | ₹162.82 |
| EPS - Basic | ₹17.15 | ₹15.19 | ₹12.03 | ₹7.50 |
| EPS - Diluted | ₹17.02 | ₹15.07 | ₹11.97 | ₹7.50 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹539.30 | ₹458.60 | ₹363.05 | ₹226.50 |
| Income before WC changes | ₹577.80 | ₹536.80 | ₹454.44 | ₹313.56 |
| Change in Assets | -₹47.70 | ₹1.10 | -₹174.60 | -₹166.97 |
| Change in Liabilities | ₹71.80 | ₹94.70 | -₹41.38 | ₹220.80 |
| Change in WC | ₹24.10 | ₹95.80 | -₹215.98 | ₹53.82 |
| Cash flow from Operations | ₹441.90 | ₹507.70 | ₹130.22 | ₹297.04 |
| Cash flow from Investing | -₹682.70 | -₹327.20 | -₹893.35 | -₹160.21 |
| Cash flow from Financing | ₹287.50 | -₹66.20 | ₹333.09 | ₹233.48 |
| Total Cash Flow | ₹46.70 | ₹114.30 | -₹430.04 | ₹370.31 |
| Cash (Start of the year) | ₹188.60 | ₹73.60 | ₹506.28 | ₹133.36 |
| Cash (End of the year) | ₹241.00 | ₹188.60 | ₹73.59 | ₹506.28 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹795.90 | ₹754.80 | ₹755.20 | ₹223.44 |
| Current Assets | ₹2,530.00 | ₹1,790.80 | ₹1,448.70 | ₹1,130.03 |
| Total Assets | ₹3,325.90 | ₹2,545.60 | ₹2,203.90 | ₹1,353.47 |
| Current Liabilities | ₹564.50 | ₹610.90 | ₹489.10 | ₹440.44 |
| Net Current Asset | ₹1,965.50 | ₹1,179.90 | ₹959.60 | ₹689.59 |
| Non-Current Liabilities | ₹145.80 | ₹505.60 | ₹651.00 | ₹149.13 |
| Equity Capital | ₹2,615.60 | ₹1,429.10 | ₹1,063.80 | ₹763.90 |
| Total Equity & Liabilities | ₹3,325.90 | ₹2,545.60 | ₹2,203.90 | ₹1,353.47 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,093.60 | ₹1,045.60 | ₹1,005.70 | ₹836.70 |
| Other Income | ₹90.40 | ₹50.30 | ₹36.80 | ₹27.80 |
| Total Revenue | ₹1,184.00 | ₹1,095.90 | ₹1,042.50 | ₹864.50 |
| Total Expenses | ₹945.50 | ₹915.30 | ₹865.90 | ₹694.60 |
| Profit Before Tax | ₹238.50 | ₹180.60 | ₹176.60 | ₹169.90 |
| Tax | ₹57.20 | ₹42.70 | ₹46.40 | ₹37.20 |
| Profit After Tax | ₹181.30 | ₹137.90 | ₹130.20 | ₹132.70 |
| EPS - Basic | ₹7.64 | ₹6.22 | ₹5.89 | ₹6.05 |
| EPS - Diluted | ₹7.64 | ₹6.17 | ₹5.86 | ₹6.01 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹238.50 | ₹180.60 | ₹176.60 | ₹169.90 |
| Income before WC changes | ₹198.20 | ₹183.10 | ₹209.40 | ₹185.40 |
| Change in Assets | ₹9.30 | -₹3.00 | -₹107.00 | -₹173.20 |
| Change in Liabilities | -₹7.90 | ₹45.40 | ₹21.30 | ₹61.90 |
| Change in WC | ₹1.40 | ₹42.40 | -₹85.70 | -₹111.30 |
| Cash flow from Operations | ₹129.00 | ₹176.20 | ₹81.90 | ₹38.20 |
| Cash flow from Investing | -₹824.70 | -₹187.70 | -₹47.90 | -₹266.70 |
| Cash flow from Financing | ₹717.30 | -₹15.80 | -₹16.90 | ₹244.90 |
| Total Cash Flow | ₹21.60 | -₹27.30 | ₹17.10 | ₹16.40 |
| Cash (Start of the year) | ₹13.20 | ₹41.80 | ₹27.80 | ₹11.60 |
| Cash (End of the year) | ₹35.20 | ₹13.20 | ₹41.80 | ₹27.80 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹931.70 | ₹469.30 | ₹334.80 | ₹315.60 |
| Current Assets | ₹1,218.00 | ₹751.00 | ₹702.90 | ₹534.50 |
| Total Assets | ₹2,149.70 | ₹1,220.30 | ₹1,037.70 | ₹850.10 |
| Current Liabilities | ₹189.50 | ₹198.10 | ₹169.40 | ₹140.70 |
| Net Current Asset | ₹1,028.50 | ₹552.90 | ₹533.50 | ₹393.80 |
| Non-Current Liabilities | ₹72.00 | ₹68.40 | ₹73.00 | ₹59.40 |
| Equity Capital | ₹1,888.20 | ₹953.80 | ₹795.30 | ₹650.00 |
| Total Equity & Liabilities | ₹2,149.70 | ₹1,220.30 | ₹1,037.70 | ₹850.10 |
About INDEGENE LIMITED
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
INDEGENE LIMITED Financial Highlights
- Revenue: INDEGENE LIMITED reported revenue of ₹3,582.50 crore in FY26 vs ₹2,946.50 crore in FY25. It showed an increase of 21.58% on a yearly basis.
- Operating Profit: INDEGENE LIMITED reported an operating profit of ₹525.00 crore in FY26 vs ₹539.30 crore in FY25. It showed a decrease of 2.65% on a year-on-year basis.
- Net Profit: INDEGENE LIMITED reported a net profit of ₹401.10 crore in FY26 vs ₹406.70 crore in FY25. It showed a decrease of 1.38% on a yearly basis.
INDEGENE LIMITED Quarterly Result Highlights
- INDEGENE LIMITED reported revenue of ₹1,014.20 crore in Mar 2026, compared with ₹961.50 crore in Dec 2025, representing an increase of 5.48% on a quarter-on-quarter (QoQ) basis.
- INDEGENE LIMITED reported an operating profit of ₹105.10 crore in Mar 2026, compared with ₹134.70 crore in Dec 2025, representing a decrease of 21.97% on a quarter-on-quarter (QoQ) basis.
- INDEGENE LIMITED reported a profit of ₹79.70 crore in Mar 2026, compared with ₹102.90 crore in Dec 2025, reflecting a decrease of 22.55% on a QoQ basis.
- The earnings per share (EPS) of INDEGENE LIMITED stood at ₹17.15 during Mar 2026.
Similar Stocks
FAQs on INDEGENE LIMITED Share Price
What is INDEGENE LIMITED share price today?
INDEGENE LIMITED share price is ₹508.30 as on 03 Jul, 2026, 15:52 IST.
How has the INDEGENE LIMITED share price performed in the past?
In the last 1 year, INDEGENE LIMITED delivered a return of -10.23%. The INDEGENE LIMITED share price hit a high of ₹596.80 and low of ₹414.00.
How much is the Mutual Fund shareholding in INDEGENE LIMITED shares?
The Mutual Fund Shareholding in INDEGENE LIMITED was 4.70% at the end of Mar 2026.
What is the the 52-week high and low of INDEGENE LIMITED shares ?
The 52-week high and low of INDEGENE LIMITED share is ₹596.80 and ₹414.00 as of 03 Jul, 2026.
What is the market cap of INDEGENE LIMITED?
The market capitalisation of INDEGENE LIMITED is ₹12,397.30 Crores as on 03 Jul, 2026.
What are the stock symbols of INDEGENE LIMITED?
The stock symbol of INDEGENE LIMITED is INDGN on the NSE, 544172 on the BSE, and the ISIN is INE065X01017.
What was yesterday's closing price of INDEGENE LIMITED shares ?
INDEGENE LIMITED shares closed yesterday at ₹514.45 on NSE & ₹514.60 on BSE
How to buy INDEGENE LIMITED shares?
To buy INDEGENE LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy INDEGENE LIMITED shares on Holidays?
No, shares of INDEGENE LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell INDEGENE LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of INDEGENE LIMITED?
The PE and PB ratio of INDEGENE LIMITED is 30.91 and 3.95 respectively, as on 03 Jul, 2026, 15:52 IST.